Barrett’s Esophagus is associated with long-term gastro-esophageal reflux disease (GERD) and is a risk factor for esophageal cancer. Current practice is to screen select patients who have multiple risk factors for esophageal cancer and monitor those patients diagnosed with Barrett's Esophagus for development of precancerous change (dysplasia). Patients who are at higher risk of progressing to esophageal cancer may benefit from endoscopic therapy.
ISDE endorsed and sponsored the following research:
Additional information can be found below.
Multidisciplinary Approaches to Early Barrett's Cancer Virtual Presentation
The Multidisciplinary Approaches to Early Barrett’s Cancer virtual presentation was held on November 18, 2020. Moderated by Sheila Krishnadath, Amsterdam University Medical Center (The Netherlands) and Prateek Sharma, University of Kansas (USA) the 90 minute presentation is available in four segments below. Watch different segments when you have time or all at once, the choice is yours.
Part 2 | Endoscopic Resection (Japanese Perspective) with Seiichiro Abe
Part 3 | Role of Surgery with George Hannah
Part 4 | Surveillance and Follow-up with Kenneth Wang
ISDE wishes to recognize and thank the following individuals for their contributions to this virtual presentation:
ISDE News Corner